PO.TB10.14 · 肿瘤生物学

Pseudomonas来源的LPS促进甲状腺乳头状癌的转移行为,而桥本甲状腺炎可减弱这种转移

Pseudomona s-derived LPS promotes metastatic behavior in papillary thyroid cancer metastasis is attenuated by Hashimoto's thyroiditis

海报缩略图:Pseudomonas来源的LPS促进甲状腺乳头状癌的转移行为,而桥本甲状腺炎可减弱这种转移
编号 4894 展板 10 时间 4/21 09:00–12:00 区域 Section 29 主讲 Yue Che, MBChB
分会场 Microbiome-Tumor-Immune Crosstalk
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Yue Che, Wei Kou, Haoran Feng, Qiwu Zhao, Zhuoran Liu, Jie Kuang, Weihua Qiu

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

摘要 Abstract

中文摘要
背景:肿瘤内微生物群可通过免疫和代谢相互作用影响癌症进展。甲状腺乳头状癌(PTC)常与桥本甲状腺炎(HT)共存,后者是一种可重塑肿瘤免疫微环境的自身免疫性疾病。然而,微生物来源的分子如何促进PTC转移,以及自身免疫细胞因子如何调节这些效应,目前仍知之甚少。 方法:采用16S rRNA测序对75例PTC患者的肿瘤组织及配对的癌旁组织进行分析,并使用PICRUSt2推断微生物功能通路。通过划痕愈合实验和Transwell实验评估Pseudomonas来源脂多糖(LPS)的促转移活性,并用多黏菌素B确认LPS特异性。通过Western blot分析NF-κB活化及EMT标志物。为模拟HT的自身免疫细胞因子环境,用重组IFN-gamma处理PTC细胞。为进行体内验证,将经LPS刺激的PTC细胞静脉注射入NCG小鼠,建立自发性肺转移模型。 结果:伴淋巴结转移(LNM)的患者表现出Pseudomonas丰度升高及预测的LPS生物合成活性增强。相比之下,与HT⁻肿瘤相比,HT⁺肿瘤的Pseudomonas水平降低、LPS通路活性减弱。在校正年龄和TNM分期后,在HT亚组内Pseudomonas丰度仍与LNM呈正相关。倾向评分匹配的中介分析进一步表明,HT对LNM具有保护作用,而Pseudomonas的促转移效应部分抵消了这种保护作用。体外实验中,Pseudomonas来源的LPS通过TLR4-NF-κB活化以剂量和时间依赖的方式促进PTC细胞迁移和侵袭,同时伴有磷酸化NF-κB和N-cadherin升高;这些效应可被多黏菌素B显著减弱。在HT样细胞因子环境下,IFN-gamma明显减弱了LPS诱导的NF-κB活化和侵袭行为。体内实验中,接受LPS预处理PTC细胞的小鼠肺转移灶数量显著增多。 结论:Pseudomonas在PTC中作为潜在的促转移细菌发挥作用,其LPS通过TLR4-NF-κB-EMT通路促进PTC细胞侵袭性。HT与Pseudomonas丰度降低相关,从而削弱这一促转移信号传导,并促成HT患者中所观察到的较低LNM风险。这些发现凸显了微生物-免疫相互作用在PTC转移中的重要性,并提示了PTC预防和治疗的潜在治疗靶点。
查看英文原文 English abstract
Background: Intratumoral microbiota can influence cancer progression through immune and metabolic interactions. Papillary thyroid cancer (PTC) frequently coexists with Hashimoto's thyroiditis (HT), an autoimmune condition that remodels the tumor immune microenvironment. However, how microbe-derived molecules contribute to PTC metastasis, and how autoimmune cytokines modulate these effects, remains poorly understood. Methods: Tumor and matched adjacent tissues from 75 PTC patients were analyzed using 16S rRNA sequencing, and microbial functional pathways were inferred with PICRUSt2. The pro-metastatic activity of Pseudomonas -derived lipopolysaccharide (LPS) was evaluated using wound-healing and Transwell assays, with polymyxin B to confirm LPS specificity. NF-κB activation and EMT markers were analyzed by Western blotting. To model the autoimmune cytokine milieu of HT, PTC cells were treated with recombinant IFN-gamma. For in vivo validation, LPS-stimulated PTC cells were injected intravenously into NCG mice to establish a spontaneous lung metastasis model. Results: Patients with lymph node metastasis (LNM) exhibited increased Pseudomonas abundance and enhanced predicted LPS biosynthetic activity. In contrast, HT⁺ tumors showed reduced Pseudomonas levels and diminished LPS pathway activity compared with HT⁻ tumors. After adjusting for age and TNM stage, Pseudomonas abundance remained positively associated with LNM within the HT subgroup. Propensity score-matched mediation analysis further indicated that HT conferred a protective effect against LNM, whereas the pro-metastatic effect of Pseudomonas partially counteracted this protection. In vitro , Pseudomonas -derived LPS promoted PTC cell migration and invasion in a dose- and time-dependent manner through TLR4-NF-κB activation, accompanied by increased phosphorylated NF-κB and N-cadherin; these effects were substantially diminished by polymyxin B. Under an HT-like cytokine environment, IFN-gamma markedly attenuated both LPS-induced NF-κB activation and invasive behavior. In vivo , mice receiving LPS-pretreated PTC cells developed significantly more pulmonary metastatic foci. Conclusions: Pseudomonas functions as a potential pro-metastatic bacterium in PTC with its LPS promoting PTC cell invasiveness through TLR4-NF-κB-EMT pathway. HT is associated with reduced Pseudomonas abundance, weakening this pro-metastatic signaling and contributing to the lower LNM risk observed in HT patients. These findings highlight the importance of microbial-immune interactions in PTC metastasis and suggest potential therapeutic targets for PTC prevention and treatment.
利益披露 Disclosure
Y. Che, None.. W. Kou, None.. H. Feng, None.. Q. Zhao, None.. Z. Liu, None.. J. Kuang, None.. W. Qiu, None.

← 返回 AACR 2026 检索